Breaking Ebola Outbreak in Eastern Congo Becomes Fastest Growing in History Tate Brothers Fight Extradition to UK Amid Flight Risk Concerns Karoline Leavitt to Step Down as White House Press Secretary 11 Charged in Multifaceted Green Card Fraud Scheme Targeting Chinese Nationals Nick Reiner Indicted on Murder Charges in Parents’ Deaths

Wednesday August 12, 2026

Reporter

Eikon Therapeutics, Inc.

4Articles Published

5Communities Covered

Published Articles

Press Release

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Aug 11

Press Release

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Aug 10

Press Release

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Jul 27

Press Release

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

Jul 20